Legal Representation
Attorney
Charles P. LaPolla
USPTO Deadlines
Next Deadline
786 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20220222)
Due Date
February 22, 2028
Grace Period Ends
August 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 22, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jul 26, 2022 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
| Jul 26, 2022 | XXCR | P | GENERIC MADRID TRANSACTION CREATED | Loading... |
| May 22, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Feb 22, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 7, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 7, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 6, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Nov 17, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Nov 17, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Nov 17, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 4, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 3, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 2, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 2, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 24, 2021 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| May 3, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| May 3, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Apr 29, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Apr 28, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 21, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 5, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Dec 30, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 24, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Adhesive dermal patches with a medical purpose for use in the treatment of musculoskeletal disorders, nervous system disorders, cardiovascular disorders, lymphatic disorders, digestive disorders, endocrine system disorders, reproductive system disorders and excretory system disorders; adhesive transdermal patches with a medical purpose for use in the treatment of musculoskeletal disorders, nervous system disorders, cardiovascular disorders, lymphatic disorders, digestive disorders, endocrine system disorders, reproductive system disorders and excretory system disorders; analgesic anti-inflammatory transdermal patches
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of two concentric circles with the center of the circles containing the design of a globe and the Vitruvian Man; the stylized wording "ANF THERAPY" appears on the top portion of the circle with the stylized wording "AMINO NEURO FREQUENCY" appearing on the bottom portion of the circle; the stylized number "20" appears on the left portion of the circle with the stylized number "12" appearing on the right portion of the circle; the stylized wording ""When nothing Else helps!"" appears below the circle design.
Pseudo Mark
ANF THERAPY TWO THOUSAND TWELVE AMINO NEURO FREQUENCY "WHEN NOTHING ELSE HELPS!"; ANF THERAPY TWENTY TWELVE AMINO NEURO FREQUENCY "WHEN NOTHING ELSE HELPS!"; ANF THERAPY TWO ZERO ONE TWO AMINO NEURO FREQUENCY "WHEN NOTHING ELSE HELPS!"
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ANF THERAPY", "2012", AND "AMINO NEURO FREQUENCY"